Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADALIMUMAB-RYVK for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 23 adverse event reports in the FDA FAERS database where ADALIMUMAB-RYVK was used for Psoriasis.

Most Reported Side Effects for ADALIMUMAB-RYVK

Side Effect Reports % Deaths Hosp.
Off label use 70 15.1% 7 10
Product dose omission issue 67 14.5% 3 13
Crohn's disease 65 14.0% 0 7
Inappropriate schedule of product administration 57 12.3% 8 19
Rheumatoid arthritis 47 10.2% 2 9
Death 45 9.7% 44 12
Diarrhoea 43 9.3% 2 13
Arthralgia 42 9.1% 1 7
Pain 42 9.1% 1 11
Fatigue 39 8.4% 0 9
Drug ineffective 38 8.2% 2 12
Abdominal pain 37 8.0% 0 7
Malaise 31 6.7% 4 4
Headache 26 5.6% 0 5
Product dispensing issue 24 5.2% 0 5

Other Indications for ADALIMUMAB-RYVK

Crohn's disease (133) Rheumatoid arthritis (107) Ankylosing spondylitis (43) Colitis ulcerative (40) Hidradenitis (34) Psoriatic arthropathy (33) Product used for unknown indication (30) Uveitis (8)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

ADALIMUMAB-RYVK Full Profile All Psoriasis Drugs ADALIMUMAB-RYVK Demographics ADALIMUMAB-RYVK Timeline